| NanoLogix
Exhibiting at National Hydrogen Association Conference |
SHARON,
PA--(MARKET WIRE)--Mar 20, 2007 -- NanoLogix, Inc. (Other OTC:NNLX.PK
- News) announced
today that the company is exhibiting both their Hydrogen Bioreactor
Technology and Hydrogen Engine Conversions at the 2007 National
Hydrogen Association Annual Conference in San Antonio .hydrogenexpo.com.
Senior
Vice President William Hartman of NanoLogix and David Hartman,
the Chief Engineer and President of NanoLogix's hydrogen engine
conversion partner, Precision Performance Company, will be in
Booth #146 March 20th and 21st. In addition, Research Paper #3306
"Microbial Production of Hydrogen from Sugar-rich Wastewater"
by Gannon University Associate Professor Dr. Harry Diz will be
presented. Dr. Diz has managed research at NanoLogix pilot hydrogen
bioreactor at Welch's Grape Juice Factory. The research paper
documents the results achieved. Dr. Diz concludes in the paper
"Hydrogen production was sustained over more than six months
of operation while methane production was controlled and limited.
This experience confirmed the ability to maintain a hydrogen-generating
culture in an industrial setting over an extended period of time."
Dana
Allen, Vice President of Strategic Partnering for NanoLogix, stated,
"The advantage NanoLogix has in hydrogen production is that
unlike conventional hydrogen production that requires the wasteful
use of natural gas or electricity, our bioreactor actually creates
energy (hydrogen) out of wastewater. It not only produces hydrogen
as a renewable source of energy, it also cleans the water. Hydrogen
is known as a wonderful and environmentally friendly fuel to use,
which it is, the problem is how to create it, energy density,
storage and transportation. The patented NanoLogix bioreactor
shows great promise to solve the remaining problems. By producing
from wastewater (generally a free feedstock) and immediately converting
it to electrical, mechanical or heat power on site, all these
issues are covered. The existing highly efficient electrical grid
becomes the method of transportation when the power generated
exceeds local demand. We look forward to large scale implementation
of this technology."
This
year, for the first time Hydrogen Expo US features a Hydrogen-from-Renewables
Pavilion with four exhibitors: NanoLogix, Powertech Labs, Ecotality
and Sandia National Laboratories. "We expect this pavilion
to grow in future years," commented an Expo official. "Additionally,
exhibitors such as Ballard or Proton Power Systems, whose products
integrate easily with renewable energy technologies, will have
individual displays," as noted in an earthtoys.com
article.
NanoLogix
hydrogen engine conversions have been well received in the market
with sales in the first month of availability. Current prices
range from $1,100 for a Briggs&Stratton 7.5 HP engine to
$2,200 for 5.5 KW generator with a Briggs&Stratton 10 HP
engine. These prices include hydrogen regulators and hose. A
video of a Hydrogen engine conversion running can be seen at
nanologix.movie page . The engine conversion
video will be updated later with a professional video.
About
NanoLogix, Inc.
NanoLogix
is an industry innovator in the research, development, and commercialization
of nano-biotechnologies, applications and processes. The Company
has developed and owns or has rights to 32 patents related to
various medical technologies, 5 of which also have hydrogen-generation
aspects. In the past year the Company has filed an additional
28 patent applications for discoveries related to hydrogen bioreactors,
medical testing, and innovative medical treatments potentially
related to leukemia and sepsis. NanoLogix is presently operating
a hydrogen bioreactor at Welch's Food and has recently signed
an agreement with the City of Erie Wastewater Treatment Plant
for a prototype bioreactor installation. While much of the Company's
current focus is on the production of hydrogen from agricultural
feedstock, industrial wastewater and municipal waste streams in
an effort to meet the need for economic sources of clean fuel,
the medical heritage of the Company has not been neglected. NanoLogix-developed
patents are used to design and market diagnostic test kits for
use in early detection of the bacteria present in infectious and
noninfectious human diseases such as tuberculosis, pneumonia,
HIV/AIDS, cancer, and cystic fibrosis. The company also owns a
patent for the non-toxic induction of apoptosis ('cell suicide')
for the treatment of cancer. For more information on the Company,
visit nanologixinc.com.
This
press release contains statements, which may constitute "forward-looking
statements" within the meaning of the Securities Act of 1933
and the Securities Exchange Act of 1934, as amended by the Private
Securities Litigation Reform Act of 1995. Those statements include
statements regarding the intent, belief or current expectations
of NanoLogix, Inc., and members of its management as well as the
assumptions on which such statements are based. Prospective investors
are cautioned that any such forward-looking statements are not
guarantees of future performance and involve risks and uncertainties,
and that actual results may differ materially from those contemplated
by such forward-looking statements. The Company undertakes no
obligation to update or revise forward-looking statements to reflect
changed assumptions, the occurrence of unanticipated events or
changes to future operating results.
|
|
Monday
June 25,
2007 NanoLogix Inc. Announces Improvements in Operations and Cash
Flow
May
24, 2007: NanoLogix
Files Five Patents for Ultra Fast BioNanoChannel(TM) Diagnostic
Technology, Prepares for Commercialization
March
27, 2007: NanoLogix
Receives 1st Royalty Payment From Joint Venture
March
20, 2007: Nanologix Exhibiting
at National Hydrogen Association Conference
March
10, 2007: Article BIOwaste
Blog - Producing Hydrogen From Wastewater And MSW
March
18, 2007: Check here for more information
on Hydrogen Conversion Engines Precision Performance.
February
27, 2007: Nanologix
Announces New Chairman And Chief Executive Officer
February
27, 2007: Bret
Barnhizer and Dana Allen Elected to NanoLogix Board of Directors
View
Press Release Archives
New!
NanoLogix Videos and Newscasts.
See several of our technologies
in action.
|
